Pharmacokinetics (PK) and tolerability of single and multiple doses of bosentan, an oral dual endothlein receptor antagonist, in children with pulmonary arterial hypertension

被引：0
|
作者：
Barst, RJ
Ivy, D
Widlitz, AC
Moore, K
Doran, A
van Giersbergen, P
Nguyen, N
Gaitonde, MD
机构：
[1] Columbia Univ Coll Phys & Surg, New York, NY 10032 USA
[2] Univ Colorado, Childrens Hosp, Denver, CO 80202 USA
[3] Actelion Pharmaceut Ltd, Allschwil, Switzerland
来源：
CIRCULATION | 2002年 / 106卷 / 19期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2239
引用
收藏
页码：450 / 450
页数：1
相关论文
共 50 条
  • [41] Multiple dose pharmacokinetics (PK) and pharmacodynamics (PD) of the reversible oral ADP receptor antagonist AZD6140
    Peters, G.
    Butler, K.
    Winter, H. R.
    Mitchell, P. D.
    EUROPEAN HEART JOURNAL, 2006, 27 : 758 - 758
  • [42] Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Novel CRTH2 Antagonist BI 1021958 at Single Oral Doses in Healthy Men and Multiple Oral Doses in Men and Women With Well-Controlled Asthma
    Fowler, Andy
    Koenen, Ruediger
    Hilbert, James
    Blatchford, Jon
    Kappeler, Dominik
    Benediktus, Ewald
    Wood, Chester
    Gupta, Abhya
    JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 57 (11): : 1444 - 1453
  • [43] Pharmacokinetics, tolerability, and safety of pirfenidone (PFD), an antifibrotic agent, following single and multiple oral doses in healthy volunteers
    Shi, Shaojun
    Wu, Jianhong
    Chen, Huating
    Chen, Hui
    Wu, Jun
    Zeng, Fandian
    ACTA PHARMACOLOGICA SINICA, 2006, 27 : 197 - 197
  • [44] Single-and multiple-dose tolerability, safety, pharmacokinetics, and pharmacodynamics of the dual endothelin receptor antagonist aprocitentan in healthy adult and elderly subjects
    Sidharta, Patricia N.
    Melchior, Meggane
    Kankam, Martin K.
    Dingemanse, Jasper
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2019, 13 : 949 - 964
  • [45] Pharmacokinetics, pharmacodynamics, tolerability and safety of single ascending doses of ticagrelor, a reversibly binding oral P2Y12 receptor antagonist, in healthy subjects
    Teng, Renli
    Butler, Kathleen
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 66 (05) : 487 - 496
  • [46] Acute Hemodynamic Effects of Single Oral Dose of Bosentan in Patients with Pulmonary Arterial Hypertension Related to Congenital Heart Disease
    Ajami, Gholamhossein
    Ahmadipour, Maryam
    Amoozgar, Hamid
    Bourzoee, Mohammad
    Cheriki, Sirous
    Shakiba, Ali Mohammad
    Edraki, Mohammad Reza
    CONGENITAL HEART DISEASE, 2014, 9 (04) : 343 - 348
  • [47] Pharmacokinetics, pharmacodynamics, tolerability and safety of single ascending doses of ticagrelor, a reversibly binding oral P2Y12 receptor antagonist, in healthy subjects
    Renli Teng
    Kathleen Butler
    European Journal of Clinical Pharmacology, 2010, 66 : 487 - 496
  • [48] Effect of the oral endothelin antagonist bosentan on the clinical, exercise, and haemodynamic status of patients with pulmonary arterial hypertension related to congenital heart disease
    Apostolopoulou, SC
    Manginas, A
    Cokkinos, DV
    Rammos, S
    HEART, 2005, 91 (11) : 1447 - 1452
  • [49] Treatment of Pulmonary Hypertension Secondary to Left Heart Insufficiency with a Dual Endothelin Receptor Antagonist (Bosentan®) in Patients Awaiting Heart Transplantation
    Schulz, U.
    Tenderich, G.
    Schulte-Eistrup, S.
    Koerfer, R.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2009, 28 (02): : S147 - S147
  • [50] Safety, Tolerability and Pharmacokinetics Study in Patients with Pulmonary Arterial Hypertension (PAH) Temporarily Switching from Oral to IV Selexipag
    Klose, H.
    Chin, K.
    Ewert, R.
    Gall, H.
    Parambil, J.
    Poch, D.
    Seyfarth, H.
    Axelsen, L.
    Schmitz, S. Hsu
    Stein, C.
    Preston, I.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2019, 38 (04): : S490 - S490
12345